CRL
Charles River Laboratories International Inc
Price:  
181.39 
USD
Volume:  
792,289.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRL WACC - Weighted Average Cost of Capital

The WACC of Charles River Laboratories International Inc (CRL) is 8.1%.

The Cost of Equity of Charles River Laboratories International Inc (CRL) is 9.35%.
The Cost of Debt of Charles River Laboratories International Inc (CRL) is 4.30%.

Range Selected
Cost of equity 7.60% - 11.10% 9.35%
Tax rate 17.20% - 17.70% 17.45%
Cost of debt 4.00% - 4.60% 4.30%
WACC 6.6% - 9.5% 8.1%
WACC

CRL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.81 1.11
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.60% 11.10%
Tax rate 17.20% 17.70%
Debt/Equity ratio 0.28 0.28
Cost of debt 4.00% 4.60%
After-tax WACC 6.6% 9.5%
Selected WACC 8.1%